The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
Authors
Keywords
-
Journal
Microorganisms
Volume 9, Issue 8, Pages 1731
Publisher
MDPI AG
Online
2021-08-16
DOI
10.3390/microorganisms9081731
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 vaccines: where we stand and challenges ahead
- (2021) Guido Forni et al. CELL DEATH AND DIFFERENTIATION
- Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses
- (2021) Andrea Citarella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
- (2021) Valentina Gaidano et al. Cancers
- Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication
- (2021) Anna Luganini et al. ANTIVIRAL RESEARCH
- An update review of emerging small-molecule therapeutic options for COVID-19
- (2021) Dengke Tian et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety
- (2021) Stefano Sainas et al. JOURNAL OF MEDICINAL CHEMISTRY
- High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome
- (2021) Paulo Caceres et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- The pathway to pyrimidines: The essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain
- (2020) Monika Löffler et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- and Animal Models for SARS-CoV-2 research
- (2020) Kazuo Takayama TRENDS IN PHARMACOLOGICAL SCIENCES
- Acute kidney injury in critically ill patients with COVID-19
- (2020) Paul Gabarre et al. INTENSIVE CARE MEDICINE
- Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
- (2020) Yechun Xu et al. Protein & Cell
- Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
- (2020) Rui Xiong et al. Protein & Cell
- SARS-CoV-2 renal tropism associates with acute kidney injury
- (2020) Fabian Braun et al. LANCET
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms
- (2020) Elham Ahmadian et al. REVIEWS IN MEDICAL VIROLOGY
- Antiviral Drug Discovery To Address the COVID-19 Pandemic
- (2020) Douglas D. Richman mBio
- The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
- (2020) Jeremy Luban et al. VIRUS RESEARCH
- IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
- (2020) Friedrich Hahn et al. Viruses-Basel
- One year update on the COVID-19 pandemic: Where are we now?
- (2020) Sanjay Kumar Mishra et al. ACTA TROPICA
- Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor
- (2019) Godefridus J. Peters NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells
- (2019) Elena Garreta et al. NATURE MATERIALS
- Broad-spectrum coronavirus antiviral drug discovery
- (2019) Allison L. Totura et al. Expert Opinion on Drug Discovery
- Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors
- (2019) Yiqing Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool
- (2019) Amesh Adalja et al. Expert Review of Anti-Infective Therapy
- Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
- (2019) Ariane J. Brown et al. ANTIVIRAL RESEARCH
- Dihydroorotate dehydrogenase inhibitors in anti-infective drug research
- (2019) Donatella Boschi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors
- (2018) Stefano Sainas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors
- (2016) Clément Grandin et al. ANTIVIRAL RESEARCH
- Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
- (2016) Richard M Deans et al. Nature Chemical Biology
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis
- (2011) Q.-Y. Wang et al. JOURNAL OF VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started